Welcome to: Rimonabant Information Source (cheapest generic rimonabant)

buy Rimonabant and lose weight
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 

Effective weight loss with Rimonabant

This treatment of obesity is like a blessing for these patients and. It is manufactured by the French pharmaceutical company Sanofi-Aventis. What are the doses of Acomplia rimonabant? Acomplia rimonabant slimming pills are available in the form of 20mg capsules. You need your strength at the direction of your doctor. If you slimming online, you should ask the clinic on-line details of doses of Acomplia. What are the side effects of Acomplia rimonabant? The users of Acomplia slimming pills probably experience some side effects, such as it is a prescription medicine. All drugs cause some side effects among users. The most common side effects of Acomplia rimonabant are dizziness, diarrhea, nausea, vomiting, hot flushes, skin disorders, mood swings alterations, and respiratory tract infections.

Rimonabant Pricelist

Please wait while we load the price list
Acomplia (Rimonabant), the new age weight loss drug is developed by world's third largest French pharmaceutical Sanofi-Aventis, to help ever growing number of obese population across the world. This weight loss drug Rimonabant Acomplia works differently to most other weight loss drugs. Acomplia (Rimonabant) works in an entirely different way, by blocking CB1 a "pleasure center" in the brain, leading people to eat less and acting directly on fat cells to prevent weight gain. Sanofi Clinical research showst it also might help people quit smoking as well. Zimulti Acomplia is also available in USA with prescription. Obesity is the major cause of many threating diseases like high blood pressure, increase in cholestrol or cardiovascular diseases and many other such conditions which is spreading its shadows on the world.

MUNICH -- The investigational drug rimonabant, first in a new class of agents known as selective endocannabinoid type 1 receptor blockers, is looking more and more like the real deal: a potential blockbuster drug causing sustained weight loss in the obese, reversal of the metabolic syndrome, an improved cardiovascular risk profile, and increased success in smoking cessation. Interim results of the randomized double-blind placebo-controlled 1,507-patient Rimonabant in Obesity-Europe (RIO-Europe) trial showed that after 1 year on 20 mg rimonabant / day, patients lost an average of 8. 6 kg, reduced their waist circumference by 8. 5 cm, boosted their cardioprotective HDL cholesterol levels by 27%, and lowered their triglyceride levels by 11%.